title: Topical 9-cis-retinaldehyde for delivery of 9-cis-retinoic acid in mouse skin.
abstract: The 9-cis-retinoic acid (9cRA) is an endogenous ligand of retinoid X nuclear receptors (RXRs). Although the epidermis contains five times more RXRs than RARs, little is known on the activity of topical 9cRA. In order to circumvent surface isomerization of topically applied 9cRA into all-trans-retinoic acid (atRA), we used topical 9-cis-retinaldehyde (9cRAL) as a precursor of 9cRA, hypothesizing that keratinocytes would metabolize 9cRAL into 9-cis-retinoic acid (9cRA). Retinoid content was determined by HPLC analysis of mouse tail skin that had been washed after the application of 9cRAL (0.05% for 14 days) to evaluate the metabolites produced within the epidermis. Biologic activities of 9cRAL and atRAL were analysed by assessing hyperplastic and metaplastic responses, by determining epidermal thickness and the levels of mRNAs encoding for specific keratins. atRAL and derived retinoids were found in skin treated with either atRAL or 9cRAL. The metabolite pattern obtained with 9cRAL was similar to that obtained with atRAL except the presence in 9cRAL samples of an unidentified nonpolar metabolite. However, treatment with 9cRAL yielded higher atRAL and lower retinyl ester concentrations. The biologic activities (hyperplastic and metaplastic responses) resulting from topical application of 9cRAL were lower than those induced by atRAL or atRA at similar concentrations. Taken together, these data show that topical 9cRAL does not deliver significant amounts of 9cRA and exerts less biologic activity than atRAL. Contrary to atRAL, 9cRAL does not appear therefore as a pertinent candidate for topical use in humans.
authors.affiliation: Department of Dermatology, University Hospital, Geneva and DHURDV, Switzerland.
authors.forename: L
authors.initials: L
authors.lastname: Didierjean
authors.forename: J O
authors.initials: JO
authors.lastname: Sass
authors.forename: P
authors.initials: P
authors.lastname: Carraux
authors.forename: D
authors.initials: D
authors.lastname: Grand
authors.forename: O
authors.initials: O
authors.lastname: Sorg
authors.forename: C
authors.initials: C
authors.lastname: Plum
authors.forename: H
authors.initials: H
authors.lastname: Nau
authors.forename: J H
authors.initials: JH
authors.lastname: Saurat
mesh_terms: D000287:Administration, Topical; D000077556:Alitretinoin; D000818:Animals; D015870:Gene Expression / Q000187:drug effects; D006965:Hyperplasia; D007633:Keratins / Q000235:genetics; D008679:Metaplasia; D051379:Mice; D008810:Mice, Inbred C57BL; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D012172:Retinaldehyde / Q000378:metabolism / Q000494:pharmacology*; D012176:Retinoids / Q000378:metabolism; D012867:Skin / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D013237:Stereoisomerism; D013623:Tail; D014212:Tretinoin / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D012333:RNA, Messenger; D012176:Retinoids; D000077556:Alitretinoin; D014212:Tretinoin; D007633:Keratins; D012172:Retinaldehyde